A comprehensive analysis by British researchers of the way lung cancer evolves over time gives medical scientists a new means of predicting how individual patients’ tumours will develop and deciding how best to treat them.
Cancer Research UK released the results on Wednesday of a £14mn study called TracerX involving 800 patients over a nine-year period. Lung cancer is the world’s most deadly cancer, killing about 35,000 people a year in the UK.
您已閱讀18%（672字），剩餘82%（2994字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。